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in primary care using a theory-based
method
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Abstract
Background: It is advocated that interventions to improve clinical practice should be developed using a systematic
approach and intervention development methods should be reported. However, previous interventions aimed at
ensuring that older people receive appropriate polypharmacy have lacked details on their development. This study
formed part of a multiphase research project which aimed to develop an intervention to improve appropriate
polypharmacy in older people in primary care.
Methods: The target behaviours for the intervention were prescribing and dispensing of appropriate polypharmacy
to older patients by general practitioners (GPs) and community pharmacists. Intervention development followed a
systematic approach, including previous mapping of behaviour change techniques (BCTs) to key domains from the
Theoretical Domains Framework that were perceived by GPs and pharmacists to influence the target behaviours.
Draft interventions were developed to operationalise selected BCTs through team discussion. Selection of an
intervention for feasibility testing was guided by a subset of the APEASE (Affordability, Practicability, Effectiveness/
cost-effectiveness, Acceptability, Side-effects/safety, Equity) criteria.
Results: Three draft interventions comprising selected BCTs were developed, targeting patients, pharmacists and
GPs, respectively. Following assessment of each intervention using a subset of the APEASE criteria (affordability,
practicability, acceptability), the GP-targeted intervention was selected for feasibility testing. This intervention will
involve a demonstration of the behaviour and will be delivered as an online video. The video demonstrating how
GPs can prescribe appropriate polypharmacy during a typical consultation with an older patient will also demonstrate
salience of consequences (feedback emphasising the positive outcomes of performing the behaviour). Action plans
and prompts/cues will be used as complementary intervention components. The intervention is designed to facilitate
the prescribing of appropriate polypharmacy in routine practice.
Conclusion: A GP-targeted intervention to improve appropriate polypharmacy in older people has been developed
using a systematic approach. Intervention content has been specified using an established taxonomy of BCTs and
selected to maximise feasibility. The results of a future feasibility study will help to determine if the theory-based
intervention requires further refinement before progressing to a larger scale randomised evaluation.
Keywords: Polypharmacy, Intervention, Behaviour change, Prescribing, Dispensing, Theoretical domains framework,
Feasibility, APEASE
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Background
In developing interventions to improve clinical practice,
it is advocated that researchers should adopt a system-
atic approach and provide explicit reporting of the in-
tervention development process [1]. The UK Medical
Research Council’s (MRC) complex intervention frame-
work recommends that intervention development be
guided by best available evidence and appropriate theory
[2]. Systematic literature reviews can help in identifying,
appraising and pooling available evidence. This can aid
the selection of intervention components, as well as
outcome measures to include as part of the overall
evaluation. The use of appropriate theory can help in
overcoming inherent limitations where intervention
development involves a pragmatic approach based on re-
searchers’ own implicit, and potentially biased, assump-
tions as to what is likely to be effective [3, 4]. For
example, theories can be used to generate testable hy-
potheses and explore potential causal mechanisms
underlying the intervention’s effect. Although established
systematic review methodologies exist which have been
extensively detailed in the literature, the methods in-
volved in identifying and/or developing appropriate the-
ory are much less clear [5]. A recognised limitation of
the MRC framework is that it does not provide guidance
on how theory can be incorporated into the intervention
development process [6].
Interventions aimed at improving clinical practice often
require behaviour change among healthcare professionals
(HCPs). For example, a number of studies have focussed
on the implementation of different evidence-based guide-
lines by HCPs as the target behaviour [7–9]. By incor-
porating behaviour change theory into intervention
development, researchers can target causal determinants
of behaviour/behaviour change, thus making interventions
more likely to be effective [10]. This requires a clear un-
derstanding of the target behaviour, as well as knowledge
of relevant behaviour change theories, so that specific
techniques can then be used as part of the intervention to
elicit the required changes. A key challenge faced by
researchers from non-health psychology backgrounds in-
volves selecting a theory, or combination of theories, from
the vast range of existing psychological theories and using
these theories appropriately to understand and change tar-
get behaviours.
The development of the Theoretical Domains Frame-
work (TDF) of behaviour change [11] has gone some
way to help overcome this challenge. The TDF simplifies
psychological theory relevant to behaviour change, in
order to make behavioural theories more accessible to
researchers from non-health psychology backgrounds
[11]. TDF version 1 consists of 12 theoretical domains
that are relevant to changing HCPs’ behaviour: ‘Know-
ledge’; ‘Skills’; ‘Social/professional role and identity’;
‘Beliefs about capabilities’; ‘Beliefs about consequences’;
‘Motivation and goals’; ‘Memory, attention and decision
processes’; ‘Environmental context and resources’; ’Social
influences’; ‘Emotion’; ‘Behavioural regulation’; ‘Nature
of the behaviours’ [11]. Eleven of the twelve theoretical
domains are proposed to be mediators of behaviour
change with ‘Nature of the Behaviours’ being the excep-
tional domain which relates to the key characteristics of
the behaviour of interest as opposed to potential mediat-
ing mechanisms or influences [11, 12]. The TDF has
since been refined and version 2 consists of 14 theoret-
ical domains [13]. However, TDF version 1 (12 domains)
is still in use [7, 14, 15]. The TDF has been used as part
of a systematic approach to intervention development in
order to identify key theoretical domains that are per-
ceived to influence HCPs’ behaviours [1]. It provides a
theoretically-robust evidence base to inform intervention
design whereby domains are mapped to behaviour
change techniques (BCTs) which form the intervention’s
so-called ‘active ingredients’ [10, 16]. This can help re-
searchers to incorporate a theory-base into the interven-
tion development phase.
The aim of the current study which formed part of a
multiphase research project was to develop an interven-
tion to improve appropriate polypharmacy in older
people in primary care, drawing on relevant methodo-
logical advances in intervention development research,
as outlined above. The use of multiple medicines, also
termed polypharmacy, is increasingly common in older
people [17, 18] and ensuring ‘appropriate polypharmacy’
in this patient cohort, whereby prescribing is evidence-
based and reflects patients’ clinical needs, is a challenge
faced by practitioners that is of considerable clinical and
economic importance, particularly in light of continuing
growth in the size of the older population [19]. Poly-
pharmacy has been identified as the principal determin-
ant of potentially inappropriate prescribing (PIP) in
older populations [4, 5] and linked to negative clinical
consequences, including medication non-adherence,
drug-interactions and adverse drug events (ADEs) [6].
PIP in older people also places a considerable financial
burden on health services [4, 5]. The challenge of im-
proving appropriate polypharmacy is further com-
pounded by a lack of available evidence and guidelines
to inform clinical practice when prescribing for older
people who often suffer from more than one chronic
condition (i.e. multimorbidity) [20].
The approach to intervention development that under-
pinned this research project aligns with the MRC frame-
work by drawing on evidence and theory. The evidence
base is drawn from the findings of an updated Cochrane
review of interventions to improve appropriate polyphar-
macy in older people [21] which identified a limited
range of intervention types. These interventions were
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most commonly pharmaceutical care-based and typically
involved HCPs conducting medication reviews. However,
the quality of the available evidence was considered low,
owing to risks of bias in the included studies, and details
of intervention development and delivery were lacking
in published reports [21]. Accordingly, a more system-
atic approach, incorporating both evidence and theory,
was recommended for the development of future inter-
ventions [21]. The theory base for the current project
was drawn from qualitative TDF-based interviews of
general practitioners (GPs) and community pharmacists
which we have reported elsewhere [22]. During the
qualitative interview phase, key theoretical domains were
identified and mapped to BCTs that could be used as
the basis of a theory- and evidence-based intervention.
The current paper builds on this earlier work and out-
lines the systematic process that we used to develop an
intervention using previously selected BCTs.
Methods
The systematic process of intervention development in-
volved a series of steps, as illustrated in Fig. 1, and was
guided by previous related research [1, 23]. The initial
steps that laid the foundation for intervention develop-
ment (i.e. TDF-based analysis of target behaviours, map-
ping of key theoretical domains to BCTs) are reported in
detail in a related paper (see Cadogan et al. [22]) and
summarised briefly below. The current paper focuses on
how selected BCTs were used to develop an intervention
that will be tested as part of a future feasibility study.
Ethical approval was granted by the Office of Research
Ethics Committees Northern Ireland (REC reference 13/
NI/0114).
Initial steps underpinning intervention development
process
The prescribing and dispensing of medications are com-
plex processes involving both clinical and non-clinical
behaviours [24, 25] and in this project, we focussed on
the clinical behaviours performed by GPs and pharma-
cists within the clinical context of prescribing/dispensing
appropriate polypharmacy to older patients (e.g. asses-
sing appropriateness of patients’ prescriptions, providing
appropriate advice/counselling). Based on the analysis of
qualitative TDF-based interviews that were conducted
with a purposive sample of HCPs (15 GPs, 15 commu-
nity pharmacists), eight key domains were selected to
be targeted as part of an intervention involving GPs
and/or community pharmacists: ‘Skills’, ‘Beliefs about
capabilities’, ‘Beliefs about consequences’, ‘Environmental
context and resources’, ‘Memory, attention and decision
processes’, ‘Social/professional role and identity’, ‘Social
influences’, ‘Behavioural regulation’ (see Cadogan et al.
[22] for detailed results). The key theoretical domains
were selected by the multidisciplinary research team
using a consensus-based approach and guided by iden-
tified barriers and facilitators within each of the
Fig. 1 Systematic process of theory-based intervention development
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domains that could realistically be targeted using avail-
able project resources.
Using previous methodological work whereby experts
in the field used consensus-based processes to develop a
mapping framework of BCTs that could be used to tar-
get specific theoretical domains [10, 16], the research
team selected four BCTs for inclusion in an intervention
involving GPs and/or community pharmacists to im-
prove appropriate polypharmacy in older people: ‘Action
planning’, ‘Prompts/cues’, ‘Modelling or demonstrating of
behaviour’, ‘Salience of consequences’. ‘Social support or
encouragement’ was selected as an additional BCT for
inclusion in a possible community pharmacy-based
intervention. The BCT selection process was guided by
the interview data (see Cadogan et al. [22] for full details
of the mapping process).
Operationalising behaviour change techniques
Owing to the many ways in which an intervention could
be developed using selected BCTs, a discussion exercise
was undertaken by the research team to identify the full
range of options for operationalising these BCTs (i.e. de-
ciding how selected BCTs would be put into practice)
[26]. Draft interventions were developed that aimed to
ensure the prescribing/dispensing of appropriate poly-
pharmacy to older patients. GPs, community phar-
macists and patients were considered as potential
intervention targets and/or mediators. There were three
important factors that influenced this draft intervention
development process, namely, context, evidence and ex-
perience, as outlined below.
Firstly, in accordance with available guidance on TDF-
based intervention development [1], we considered the
local context (particularly current clinical practice), as
well as what was likely to be feasible and acceptable to
the target group. For example, based on the contextual
information from the analysis of the qualitative inter-
views, it was evident that in order for the intervention to
be feasible and acceptable to HCPs, it would have to be
time-efficient and easy to incorporate into routine clin-
ical practice. Equally, it was unlikely that a computer-
based prescribing alert intervention would be worth
pursuing unless issues with the clinical relevance of
existing alert systems that were raised during interviews
could be addressed [22]. Furthermore, this would have
been beyond the scope of the current project’s resources.
Secondly, we consulted the updated Cochrane review
[21] to determine if evidence existed to inform decisions
regarding mode of BCT delivery. Finally, we drew on the
multidisciplinary research team’s experience in health
psychology, pharmacy and medicine, as well as know-
ledge of relevant literature to inform decisions about
mode of BCT delivery. Based on these considerations, a
shortlist of draft interventions was formulated. The
shortlist included an outline of each draft intervention’s
content and mode of delivery.
Feasibility screening of draft interventions
Feasibility screening of the draft interventions was
undertaken by the research team to select one inter-
vention for further feasibility testing. This process was
guided by the APEASE criteria (Affordability, Practic-
ability, Effectiveness/cost-effectiveness, Acceptability,
Side-effects/safety, Equity) which have been developed
to assist researchers in designing and evaluating inter-
ventions [6]. In applying these criteria, we focussed on
the subset of criteria that we deemed most relevant to
the initial stages of intervention development (i.e. ac-
ceptability, practicability and affordability), as opposed
to those which we felt would be more applicable to
the later stage of intervention evaluation when a full-
scale trial is undertaken (i.e. effectiveness, side-effects/
safety, equity).
Results
Draft intervention development
Based on the team discussion exercise, three draft inter-
ventions that operationalised selected BCTs were devel-
oped for potential feasibility testing (Table 1). The draft
interventions targeted patients, pharmacists and GPs, re-
spectively and focused on increasing the prescribing/dis-
pensing of appropriate polypharmacy to older patients.
In developing each draft intervention, we considered the
local context (as identified from the qualitative in-
terviews [22]) and attempted to ensure that each inter-
vention would be time-efficient and relatively easy to
incorporate into routine clinical practice. We then con-
sulted the updated Cochrane review [21] to determine if
evidence existed to inform our decisions regarding mode
of BCT delivery. However, as few interventions have pre-
viously been trialled in primary care settings and specific
intervention components have not been described using
standardised terminology, such as BCTs, it was not pos-
sible to use the review findings to guide our decision
process. Hence, the rationale underpinning our chosen
mode of BCT delivery for each intervention was guided
by the research team’s experience and knowledge of rele-
vant literature, as outlined below.
Patient-targeted intervention
The use of written letters from GPs to deliver the BCT
‘Prompt/cues’ as part of the patient-targeted intervention
was based on our knowledge of previous research whereby
this mode of intervention delivery has been used to
prompt patients to reduce potentially inappropriate long-
term benzodiazepine use (i.e. a contributing factor to in-
appropriate polypharmacy in older people) [27].
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HCP-targeted interventions
The decision to use an online video to deliver the BCT
‘Modelling or demonstrating of behaviour’ as part of
both HCP-based interventions (i.e. GP and community
pharmacist) was informed by a recent project [28]. As
part of the IDEA trial (which focused on improving dia-
betes care through examining, advising and prescribing),
a complex intervention that included a video demonstra-
tion was developed to target a range of HCP behaviours
to improve the quality of care provided to a specific pa-
tient population in whom polypharmacy is also common
(i.e. patients with diabetes mellitus) [28].
The use of the GP-approved list of potential target pa-
tients (Table 1) to deliver the BCT ‘Social support or en-
couragement’ as part of the community pharmacy-based
intervention was based on our knowledge of the findings
from a previous systematic review in which GP-referral
of patients to pharmacists for medication reviews was
considered a key element reflecting collaborative care
between the two groups of HCPs [29]. Interventions in-
volving more extensive collaboration between GPs and
pharmacists are associated with significantly higher im-
plementation rates for recommendations arising from
reviews of patients’ medications compared to interven-
tions involving less collaboration [29].
Feasibility screening assessment
The results of the feasibility screening assessment using
the APEASE criteria [6] are shown in Table 2. The
patient-targeted intervention was not considered for fur-
ther evaluation for two main reasons. Firstly, the inter-
vention was intended to target patients’ behaviours as
opposed to the pre-specified target behaviours (i.e. pre-
scribing and dispensing of appropriate polypharmacy).
Secondly, the intervention was not considered to be a vi-
able option because of issues with its likely acceptability
and effectiveness. For example, owing to ethical consid-
erations involved in placing responsibility on patients to
seek an appointment with their GP, it was unlikely that
the intervention would be deemed acceptable to HCPs.
It was also noted that selected BCTs were not spe-
cifically targeting the pre-specified target behaviours (i.e.
prescribing and dispensing of appropriate polypharmacy)
as one of the BCTs (i.e. ‘Prompt/cue’) was being used to
target patients.
Due to commonalities in the GP and community
pharmacist-targeted interventions (e.g. online video
demonstration), assessments relating to acceptability and
affordability were similar. The GP-targeted intervention
was selected for further feasibility testing because it was
deemed to be more practicable than the pharmacist-led
intervention. This was because the pharmacist-led inter-
vention was heavily reliant on the co-ordination of care
between general practice and community pharmacy.
Thus, if a partnership could not be established between
the two healthcare settings, the intervention could not
be delivered as intended.
Table 1 Description of draft interventions
Intervention 1: Patient-targeted intervention
Target group: older patients (≥65 years) receiving polypharmacy
Target behaviour: not applicablea
Intervention description: The intervention would be delivered to
target patients either through the form of a letter from the GP
inviting patients to attend a review consultation (‘Prompts/cues’)
or as a coloured label that community pharmacists would attach to
patients’ dispensed medication prompting patients to visit their GP
for a review consultation (‘Prompts/cues’). GPs would then plan to
ensure that patients are prescribed appropriate polypharmacy when
they present at the practice (‘Action planning’).
Intervention 2: General practice-based intervention
Target group: GPs
Target behaviour: prescribing of appropriate polypharmacy
Intervention description: The intervention would be delivered
through a short online video (or series of videos) demonstrating
how GPs can prescribe appropriate polypharmacy during a typical
consultation with an older patient (‘Modelling or demonstrating of
behaviour’). Each video would last the duration of an average GP
consultation (approximately 10 min) and also include feedback
from both the GP and patient emphasising the positive outcomes
of the consultation (‘Salience of consequences’). As complementary
intervention components, GPs would make an explicit plan at practice
meetings of when and how they would ensure that target patients
are prescribed appropriate polypharmacy (‘Action planning’) and they
would be prompted to carry out this plan by the receptionist when
target patients present at the practice (‘Prompts/cues’).
Intervention 3: Community pharmacy-based intervention
Target group: community pharmacists
Target behaviour: dispensing of appropriate polypharmacy
Intervention description: The intervention would be delivered through
a short online video (or series of videos), similar to that outlined in the
GP-based intervention. The video would operationalise two BCTs
(‘Modelling or demonstrating of behaviour’, ‘Salience of consequences’)
by demonstrating how pharmacists can dispense appropriate
polypharmacy during a typical encounter with an older patient
and including feedback from both the pharmacist and patient
emphasising the positive outcomes of this process.
Patients would be targeted using a collaborative approach between
the GP practice and pharmacy. Patients would be identified initially
by the GP practice. A list of GP-approved patients would be provided
to the pharmacy which would authorise pharmacists to engage with
target patients when they present at the pharmacy (‘Social support or
encouragement’).
Having been provided with access to the online video(s) together
with the list of target patients, pharmacists would make an explicit
plan of when and how they would ensure that patients meeting
inclusion criteria are dispensed appropriate polypharmacy (‘Action
planning’). Pharmacists would be prompted to enact this plan when
patients present at the pharmacy either by support staff or a note
on the individual patient’s dispensing record (‘Prompts/cues’). Any
recommended changes to patients’ current medications would be
communicated to the GPs by the pharmacists.
aNot applicable: the target behaviour of this draft intervention was not one of
the two pre-specified target behaviours (i.e. prescribing and dispensing of
appropriate polypharmacy)
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Discussion
This paper describes the systematic development of an
intervention to improve appropriate polypharmacy in
older people in primary care and serves to address the
lack of theory-based and adequately described interven-
tions in the related literature [21]. The detailed analysis
of the target behaviours (i.e. prescribing and dispensing
of appropriate polypharmacy) that was undertaken using
the TDF [11] as the underpinning theoretical framework
enabled us to identify key mediators (i.e. barriers, facili-
tators) of behaviour change to target as part of the inter-
vention [22]. It has been proposed that by targeting
specific behaviour change mediators, researchers will en-
hance the likely effectiveness of interventions [10].
Hence, the intervention was specifically developed to
target identified mediators of behaviour change using
behaviour change techniques (BCTs) from an established
taxonomy [30]. The selection of BCTs was guided by
previous methodological work by experts in the field
whereby BCTs have been mapped to relevant theoretical
domains from the TDF [10, 16] (see Cadogan et al. [22]
for full details).
In comparison to the initial baseline work (i.e. TDF-
based analysis of target behaviours, mapping of key the-
oretical domains to BCTs) for which we were able to
draw on established methods and guidance [22], the de-
velopment of draft interventions using selected BCTs
proved to be a challenging process for several reasons.
Although the current BCT Taxonomy (version 1) [30]
provides definitions of each BCT and illustrative examples
of how they can be operationalised, there is no single best
approach to decide on how to draft interventions based
on a given number of BCTs. A previous review of the
TDF-based literature showed that few published studies
have progressed through the entire process of TDF-based
intervention development [12]. Within the existing litera-
ture, the methods used by individual research groups to
develop TDF-based interventions following mapping of
BCTs to key theoretical domains have varied. For example,
French et al. [1] reported that, following the mapping
process, intervention development was based on a com-
bination of the research team’s experience and feedback
from colleagues, while Kolehmainen and Francis [26] re-
ported that an advisory team was established to help in-
form the process. Hence, it would appear that there is no
consensus as to what is the most appropriate procedure
for determining how best to operationalise and deliver se-
lected BCTs as part of an intervention.
Ideally, these decisions should be guided by contextual
information gathered from key stakeholders (i.e. those
delivering/receiving intervention) and informed by avail-
able evidence. The qualitative HCP interviews helped to
provide the former, but despite having updated a
Cochrane review [21] as part of the overall project, the
findings were of limited value in informing our decision
process. Few of the interventions that were included in
the review had been conducted specifically in primary
care settings and specific intervention components had
not been characterised using standardised terminology,
such as BCTs. Hence, there was a lack of available evi-
dence on which to base decisions as to how to oper-
ationalise and deliver BCTs.
The BCT Taxonomy [30] has been used to retrospect-
ively code interventions identified through systematic re-
views [31], in addition to developing behaviour change
interventions. Although this will ultimately help to de-
velop an evidence base to inform decisions regarding
BCT operationalisation and delivery, this work is still at
an early stage. The full potential of characterising behav-
iour change intervention components in terms of BCTs
will not be realised until problems with the reporting of
complex interventions are addressed, such as the lack of
detailed description of intervention development and de-
livery that was identified in the Cochrane review [21].
Table 2 Feasibility screening assessment of draft interventions
(guided by a subset of APEASE criteriaa)
Intervention 1: Patient-targeted intervention
Strength: Practicable and affordable intervention.
Limitation: Intervention does not target the pre-specified target
behaviours directly (i.e. prescribing and dispensing of
appropriate polypharmacy) and does not operationalise
all selected BCTs (e.g. ‘Modelling or demonstrating of
behaviour’, ‘Salience of consequences’).
Limitation: Use of ‘Prompts/cues’ as a BCT is not directly targeting
HCPs’ behaviour in this context.
Limitation: Acceptability issues which are likely to limit the potential
effectiveness of the intervention (e.g. if pharmacists advise
patients to make an appointment when GPs do not feel
that there are any prescribing issues that need to be
addressed).
Intervention 2: General practice-based intervention
Strength: Likely to be a practicable and acceptable intervention.
Strength: Intervention can include all selected BCTs and target HCPs’
prescribing behaviour.
Limitation: Potential affordability issues with video production costs.
Limitation: Due to heterogeneity among older patients in terms of
comorbidities and prescribed medications, more than one
video may be required if intervention is to be effective.
Intervention 3: Community pharmacy-based intervention
Strength: Likely to be an acceptable intervention as it acknowledges
professional role/boundary related issues between the two
groups of HCPs.
Strength: Intervention can include all selected BCTs.
Limitation: Potential affordability issues with video production costs.
Limitation: Intervention is reliant on co-ordination of care between
the GP practice and community pharmacy which may
impact on practicability and effectiveness.
Limitation: Due to heterogeneity among older patients in terms of
comorbidities and prescribed medications, more than one
video may be required if intervention is to be effective.
aThe subset of the APEASE criteria that were applied during the feasibility
screening assessment consisted of affordability, practicability and acceptability
Cadogan et al. BMC Health Services Research  (2016) 16:661 Page 6 of 10
Recent guidance on the reporting of complex interven-
tions [e.g. TIDieR (Template for intervention description
and replication) [32], WIDER (Workgroup for Interven-
tion Development and Evaluation Research) [33]] may
go some way to help overcome these issues. In the in-
terim, decisions as to how selected BCTs should be
operationalised and delivered will rely on the judgement
of individual research teams. This process should be
based on the team members’ research experience and
knowledge of relevant literature while following existing
guidance [1] and considering the local context, as well
as what is likely to be feasible and acceptable to the tar-
get group.
The video demonstration component of the interven-
tion aligned with a ‘work smarter, not harder’ approach
that sought to limit any additional workload for GPs in
prescribing appropriate polypharmacy [34]. Thus, rather
than introducing new behaviours or tasks for GPs to
perform, we sought to enable GPs to use available time
more efficiently by demonstrating how appropriate poly-
pharmacy can be prescribed during routine consulta-
tions with older patients (‘Modelling or demonstrating
of behaviour’) and emphasising the potentially positive
consequences of performing this behaviour (‘Salience of
consequences’). It was envisaged that the video would
last the duration of an average GP consultation (i.e. ten
minutes) in order to ensure that it was considered clinic-
ally authentic by the intervention targets (i.e. GPs). The
online mode of delivery was chosen so that GPs could
access the video at a time that would be convenient for
them. The additional intervention components (i.e. ac-
tion plans, prompts/cues) sought to complement the
video demonstration by enabling GPs to overcome the
time barriers posed by the existing work environment to
performing the target behaviour through the use of ac-
tion plans and prompts/cues (Table 1). It has been pro-
posed that a ‘work smarter, not harder’ type of approach
could enhance the likelihood of achieving improvements
in patient care [34].
It must be noted that achieving appropriate polyphar-
macy in older people is a highly complex clinical challenge
and is not limited to changing GPs’ prescribing behaviour
alone. A range of other issues need to be addressed in
order to optimise medication use in older people, includ-
ing the lack of available evidence and guidelines to inform
clinical practice when prescribing for older multimorbid
patients [20] and patient-level barriers when attempting to
implement prescribing changes (e.g. disagreement with
the appropriateness of prescribing changes) [35]. In light
of this complexity, it is unlikely that a single intervention
could ever address all of the encompassing issues and
challenges. Therefore, a combination of interventions will
likely be required. The intention of the intervention devel-
oped in the current study was to introduce small, but
potentially sustainable, changes in GPs’ current clinical
practice aimed at improving prescribing for older people.
This is in accordance with available guidance on the de-
velopment of behaviour change interventions which rec-
ommends that change should be introduced incrementally
and proposes that building on small successes over time
can be more effective than trying to do too much too
quickly [6]. If the current intervention proves effective in
a future trial evaluation, it could be combined with other
interventions to form part of a large multi-strand ap-
proach to optimise medication use in older people.
The feasibility screening process was an important
methodological step in the development of our interven-
tion as there were several ways in which the combin-
ation of BCTs could have been operationalised. The
APEASE criteria [6] helped us to consider key factors
such as the likely acceptability and practicability of each
draft intervention before undertaking any formal
feasibility study. For example, due to the anticipated dif-
ficulties in the co-ordination of care between general
practices and community pharmacies and the negative
impact that this would have on the practicability of a
community pharmacy-based intervention, the GP-
targeted intervention was selected as the most viable op-
tion for further evaluation. Applying these criteria also
helped us to identify that one of the draft interventions
(i.e. the patient-targeted intervention) did not target the
pre-specified behaviours that we had set out to change
(i.e. prescribing and dispensing of appropriate polyphar-
macy). A future feasibility study will help us to deter-
mine if further refinements to the intervention are
required before progressing to a larger scale evaluation
in a randomised study.
Strengths and limitations
The main strength of this study was that it sought to
overcome limitations with previously evaluated interven-
tions to improve appropriate polypharmacy in older
people [21] by adopting a systematic approach using
both evidence and an underlying theory-base as advo-
cated by the MRC framework [2]. Interventions aimed at
improving healthcare practice have often not included
an underlying theory base [36, 37]. This prevents re-
searchers and clinicians from understanding the mecha-
nisms of change underlying the interventions’ effects. In
addition, problems have been noted with the reporting
of behaviour change interventions in the literature, such
as a lack of detailed descriptions of interventions and
the use of inconsistent terminology to characterise inter-
vention content [38]. This makes it difficult to replicate in-
terventions and to either compare the effects of different
interventions or to pool data for specific intervention
components across studies. The selection of BCTs from
an established taxonomy in the current intervention will
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ensure that the intervention content is described in detail
using standardised terminology and this will ultimately
help to overcome the above noted limitations of previous
research.
As a limitation of our approach, it must be noted that
the intervention development work was underpinned by
TDF-based qualitative interviews of healthcare profes-
sionals which limits the generalisability of the findings
[22]. However, participants were sampled across the five
administrative health areas in Northern Ireland, and this
geographical spread enhanced the transferability of the
findings. Given the similarities in general practice across
the UK, it is likely that many of the identified barriers and
facilitators under each of the theoretical domains would
be applicable to GPs across the UK. This claim is sup-
ported by the findings of a previous study that compared
qualitative TDF-based interview findings of healthcare
professionals from different countries, and identified con-
siderable overlap in terms of identified barriers and facili-
tators under a number of theoretical domains [39].
It must also be noted that there is a degree of subject-
ivity with the employed intervention development
process as selected BCTs could have been operationa-
lised in a number of different ways [1]. Hence, it is un-
certain whether another research team would have
operationalised selected BCTs in similar ways and pro-
duced exact replicates of the interventions that were de-
veloped [26]. We attempted to overcome this by drafting
a range of interventions through which selected BCTs
could be operationalised and selecting an intervention
for further testing through the feasibility screening
process that was guided by the APEASE criteria [6].
Finally, as the BCT Taxonomy [30] is a relatively new
methodological tool, further evidence is required to en-
sure that particular BCTs achieve behaviour change
through the proposed theoretical domains to which they
have been mapped by experts in the field [16]. In addition,
while our selected BCTs targeted multiple theoretical
domains (e.g. Modelling or demonstrating the behaviour
targeted ‘Skills’, ‘Beliefs about capabilities and ‘Social influ-
ences’), it is not yet clear whether targeting an increased
number of domains results in more effective interventions
[40]. However, by adopting a systematic and theory-based
approach to intervention development using the TDF and
specifying the intervention’s content in terms of BCTs, we
can now make explicit assumptions about the hypothe-
sised mechanisms of change underlying the intervention’s
effect [1]. Thus, we can now hypothesise that our GP-
targeted intervention that comprises four BCTs will effect
change in GPs’ prescribing behaviour to improve appro-
priate polypharmacy by targeting mediators of behaviour
change across eight theoretical domains. As further pro-
gress is made in conducting trial evaluations of TDF-
based behaviour change interventions, an evidence base
will begin to emerge that will help to inform the selection
of BCTs to target specific theoretical domains.
Conclusion
This paper builds on previous work in which we have
identified key theoretical domains that were perceived to
influence HCPs in prescribing and dispensing appropri-
ate polypharmacy to older people, and mapped these do-
mains to BCTs to include as part of an intervention.
Selected BCTs have been operationalised and different
draft interventions have been developed. Based on feasibil-
ity screening of the draft interventions using the APEASE
criteria, a GP-targeted intervention has been selected as
the most suitable intervention for further feasibility test-
ing. The results of a feasibility study (ISRCTN18176245)
which are currently being evaluated will help to determine
if further refinement to the theory-based intervention is
required before progressing to a larger scale trial evalu-
ation using a randomised design.
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